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INTRODUCTION 
Liposomes Microscopic phospholipid bubbles with a 
bilayered membrane structure - have received a lot of 
attention during the past 30 years as pharmaceutical 
carriers of great potential.1 More recently, many new 
developments have been seen in the area of liposomal 
drugs - from clinically approved products to new 
experimental applications, with gene delivery and cancer 
therapy still being the principal areas of interest. 
2Liposomes are microscopic vesicles composed of a 
bilayer of phospholipids or any similar amphipathic 
lipids. They can encapsulate and effectively deliver both 
hydrophilic and lipophilic substances and may be used as 
a non‐toxic vehicle for insoluble drugs.3 Liposomes are 
composed of small vesicles of phospholipids 
encapsulating an aqueous space ranging from about 0.03 
to 10 µm in diameter. 4,5The membrane of liposome is 
made of phospholipids, which have phosphoric acid 
sides to form the liposome bilayers.Liposomes can be 
manufacturing in different lipid comopsitions or by 
different method show variation in par. Size , size 
distribution, surface electrical potential, no. of lamella, 
encapsulation efficacy, Surface modification showed 
great advantage to produce liposomes of different 
mechanisims, kinetic properties and biodistribution. 
Products in the market Doxorubicin (Doxil, Myocet) (KS 
Kaposis sarcoma) Daunorubicin (Dauno Xome) 
Cytarabin artificial microscopic vesicle consisting of an 
aqueous core enclosed in one or more phospholipid 
layers, used to convey vaccines, drugs, enzymes, or other 
substances to target cells or organs.
6 Liposomes are nano 
size artificial vesicles of spherical shape. They can be 
produced from natural phospholipids and cholesterol. 
Phospholipids combine with water immediately forms a 
bi-layered sphere.7 On this account Dr. Baumann 
Cosmetic produces only liposome products without 
perfume and without chemical preservatives. Exactly the 
same phospholipids which comprise the liposome 
membrane form the walls of skin cells. Similarly, the 
intercellular substance which is found between the skin 
cells is composed of phospholipids, ceramides, 
triglyceride, free fatty acids, cholesterol and water. If 
skin cells are slightly damaged or if the intercellular 
substance is lost through aggressive cleansing methods, 
liposomes are able to perfectly replenish the missing 
lipids. Therefore the combination of phospholipids, 
ceramides and other skin-endemic lipids .A liposome is a 
tiny bubble (vesicle), made out of the same material as a 
cell membrane. Liposomes can be filled with drugs, and 
used to deliver drugs for cancer and other diseases.
9, 10,11 
 
Figure 1: Scheme of a liposome formed by 
phospholipids in an aqueous solution
ABSTRACT 
Liposome was found by Alec Bangham of Babraham Institute in Cambridge, England in 1965.In 1990; drugs with liposome 
and Amphotericin B were approved by Ireland. In 1995 America F.D.A approved liposor doxodubicin. In 1965s, it was well 
recognized that microscopic lipid vesicles, known as liposomes, could be utilized to encapsulate drugs and dyes for the 
purpose of systemic administration and drug targeting.Considerable  progress was made in 1980s, in engeneering liposomes to 
circulate longer in blood and remain intact while doing so. The liposome a microscopic spherical particle formed by a lipid 
bilayer enclosing an aqueous compartment.An artificial microscopic vesicle consisting of an aqueous core enclosed in one or 
more phospholipid layers, used to convey vaccines, drugs, enzymes, or other substances to target cells or organs. Liposome 
was discovered about 40 years ago by Bangham and coworkersand was defined as microscopic spherical vesicles that form 
when phospholipids are hydrated or exposed to anaqueous environment.Liposomes are microscopic vesicles composed of a 
bilayer of phospholipids or any similar amphipathic lipids. They can encapsulate and effectively deliver both hydrophilic and 
lipophilic substances2‐3 and may be used as a non‐toxic vehicle for insoluble drugs. Liposomes are composed of small vesicles 
of phospholipids encapsulating an aqueous space ranging from about 0.03 to 10 µm in diameter. The membrane of liposome is 
made of phospholipids, which have phosphoric acid sides to form the liposome bilayers. Liposomes can be manufacturing in 
different lipid comopsitions or by different method show variation in par. Size , size distribution, surface electrical potential, 
number of lamella, encapsulation efficacy, Surface modification showed great advantage to produce liposomes of different 
mechanisims, kinetic properties and biodistribution 
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 CLASSIFICATION 
Liposome are classified on the basis of: 
 
Fig 2: Structure of liposome based on composition and applications 
 
Fig 3: Structure of liposome based on structural parameters
10 
 
Fig 4:  Structure of liposome based on methods of preparation
 
Based on composition 
and applications
CL (Convention 
Liposomes
Neutral/negatively charged 
phospholipids & cholesterol
Fusogenic Liposomes
RSVE – Reconstituted Sendai 
Virus envelopes
pH sensitive liposomes
Using phospholipids such as PE 
or DOPE with OA
Cationic Liposomes Cationic lipids with DOPE
Long circulating 
(shealth) Liposomes
(LCL)
Made using cholesterol & 5-10% 
PEG-DSPE or GM1
Immuno-liposomes
With attached monoclonal 
antibody
Based on 
structural 
parameters
MLV –
Multilamellar
Vesicles (>0.5µm)
OLV –
Oligolamellar
Vesicles (0.1-1µm)
UV – Unilamellar
Vesicles (all size ranges)
SUV – Small Unilamellar vesicles (20-100 nm)
MUV – Medium Unilamellar vesicles
GUV – Giant Unilamellar vesicles
LUV – Large Unilamellar vesicles (>100 nm)
MVV/MV – Multivesicular
vesicle(>1µm)
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ATTRACTIVE BIOLOGICAL PROPERTIES OF 
LIPOSOMES 
• Liposomes are biocompatible. 
• Liposomes can entrap water-soluble (hydrophilic) 
pharmaceutical agents in theirinternal water 
compartment and water-insoluble (hydrophobic) 
pharmaceuticals intothe membrane. 
• Liposome-incorporated pharmaceuticals are protected 
from the inactivating effect of external conditions, yet do 
not cause undesirable side reactions. 
• Liposomes provide a unique opportunity to deliver 
pharmaceuticals into cells or even inside individual 
cellular compartments. 
• Size, charge and surface properties of liposomes can be 
easily changed simply by adding new ingredients to the 
lipid mixture before liposome preparation 
LAMELLA 
 A Lamella is a flat plate like structure that appears 
during the formation of liposomes. The Phospholipid    
bilayer  first  exists as a lamella before getting convered 
into spheres. A Lamella is a flat plate like structure that 
appears during the formation of liposomes10 
 ADVANTAGE 
 Flexibility in the structure in entrapment of water 
soluble as well as insoluble drugs. 
 Biodegradability 
 Efficient control of release. 
 Resemblance to natural membrane structures. 
 Increased targeting prospects. Biocompatible, 
completely biodegradable, non-toxic, flexible 
,nonimmunogenic. 
 Liposomes supply both a lipophilic environment and 
aqueous “milieu interne” in one system. Can protect 
encapsulated drug.  
 Reduce exposure of sensitive tissues to toxic drugs. . 
 Easy to construction. 
 Increased efficacy and therapeutic index. 
 Provides both targetting active and passive. 
 Does not accumulate in heart and so there is no  
cardiotoxicity. 
 Prevent oxidation of the drug. 
DISADVANTAGE 
 Production cost is high. 
 Leakage and fusion of encapsulated drug / 
molecules.  
 Sometimes phospholipid undergoes oxidation and 
hydrolysis like reaction.  
 Short half-life. 
 Low solubility. 
 Fewer stables. The development of liposomes at 
industrial level is difficult due to its physiological 
and physicochemical instability. 
 They are prone to degradation by oxidation and 
hydrolysis. 
 Production cost is high. 
 Leakage and fusion of encapsulated drug / 
molecules. 
 Low solubility 
 Fewer stables. 
COMPOSITION OF LIPOSOMES 
A. Phospholipids 
Naturally occurring phospholipids used in liposome 
 Phosphatidylethanolamine  
 Phosphatidylcholine  
 Phsphatidylserine 
 
 
 
• Synthetic phospholipids used in the liposomes are: 
• Dioleoyl phosphatidylcholine  
• Disteroyl phosphatidylcholine  
• Dioleoyl phosphatidylethanolamine11 
B. Cholesterol 
Cholesterol can be incorporated into phospholipids 
membrane in very high concentration up to 1:1 or 2:1 
molar ratios of cholesterol to phospatidylcholine. Being 
an amphipathic molecule, cholesterol inserts into the 
membrane with its hydroxyl group of cholesterol 
oriented towards the aqueous surface and aliphatic chain 
aligned parallel to the acyl chains in the center of the 
bilayers and also it increase the separation between 
choline head groups and eliminates the normal 
electrostatic and hydrogen bonding interaction. The 
phospholipids are arranged in such a way that the 
hydrophilic head is exposed outside and the lipophillic 
tails are aliened inside. This makes the liposomes water 
soluble molecules.
11, 12
 
 
Fig. - 5:  Structure of liposome overall composition
7 
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MECHANISM: - Liposome Formation 
 As liposomes are made up of phospholipids, they are 
amhpipathic in nature and have ability to binds both 
aqueous and polar moiety.They have polar head and 
non polar tail. 
 The polar end is mainly phosphoric acid and it will 
bound to water soluble molecule. 
 In aqueous medium the molecules in self-assembled 
structure are oriented in such way that the polar 
portion of the molecule remain in contact with in 
polar environment and at same time shields the non 
polar part. Liposomes are formed when the thin 
films are hydrated and stacks of liquid crystalline 
bilayers become fluid and swells. 
 Once these vesicle get formed, a change in vesicle 
shape and morphology required energy input in the 
form of …. Sonic energy to get SUVs and 
mechanical energy  to get LUVs. 
 However, in aqueous mixtures these molecules are 
able to form various phases, some of them are stable 
and other remains in metastable form.12,13
 
 
Fig 6:  Mechanism of liposome preparation 
HANDLING OF LIPOSOMES-
The lipids used in the preparation ofliposomes are unsatu
rated and hencesusceptible to oxidation.Also volatile sol
vents such as chloroformwhich are used will tend to evap
orate fromthe containeThus liposomes must be stored in 
an inertatmosphere of nitrogen, and in the dark, inglass v
essels with a securely fastened cap.13 
DRYING  
An important step involved in the preparation of 
liposomes is the drying of the lipid. Large  volume  
of organic  solution of  lipids is  most easily 
 dried in a rotary evaporator fitted with a 
cooling coil and a  thermo statically controlled 
water bath .Rapid  evaporation  of solvent 
 is carried out by gentle warming  (20‐40 degrees) 
under reduced pressure  (400‐700 mm Hg) 
Rapid rotation of the solvent containing flask  
increases the surface area for evaporation In cases  
where sufficient  vacuum  is  not  attainable or  if the 
 concentration  of lipids is particularly high,  
it may be difficult  to remove  the last  traces of 
 chloroform  from the  lipid  film. Therefore, 
it is recommended as a matter of 
routine that after rotary evaporation, some 
further means is employed to bring the residue to 
complete dryness .Attachment of the flask 
to the manifold of lyophilize,  and  overnight  
exposure to high vacuum is a good method.
14,15 
 
 
Fig-7: Different methods of liposomes preparations
35 
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METHOD OF PREPARATION BASED ON 
METHOD OF DISPERSION: 
 Mechanical dispersion 
 Solvent dispersion methods 
 Detergent removal methods 
MECHANICAL DISPERSION METHODS TYPES 
OF MODIFIED VESICLES 
 Lipids film hydration  by hand shaking ,non hand 
shaking and freeze drying  
 Sonication unicellular liposomes 
 Micro-emulsification liposomes 
 French Pressure Cell liposomes  
 Membrane Extrusion liposomes 
  Dried reconstituted vesicles  
 Freeze-thawed liposomes  
 PH indused vesiculation 
 Calcium indused fusion 
SOLVENT DISPERSION METHODS 
 Ethanol injection  
 Ether injection  
 Double emulsion vesicles  
 Reverse phase evaporation vesicles 
 Stable plurilamellar vesicles 
DETERGENT REMOVAL METHODS 
 Detergent  
 Dilution  
 Reconstituted Sendai virus enveloped vesicles  
PHYSICAL DISPERSION OR MECHANICAL 
DISPERSION METHOD 
Aqueous volume enclosesd usiong this method usually 5-
10%,which is very small proportion of total volune used 
for swelling .Therefore large quantity of water –soluble 
compound are wasted during sweeling .On the other 
hand lipid soluble compound cab be encapsulated to 
100% efficacy ,provided they aee not present in 
quantities that are greater than the structural component 
of the memberane. 
Lipid Film Hydration by hand shaking and non hand 
shaking:- In this methods, the lipids are casted as stacks 
of film from their organic solution using „Flash rotatory 
evaporator‟ or „hand shaking‟,The film formation will be 
takes place and the film    will be dried in presence of 
reduced Nitrogen.After the film stacks are dispersed in 
aqueous phase .Upon hydration the liquid will swell and 
peel off from wall of round bottom flask and vesiculate 
forming multi lamellarvesicles(MLVs).Liposomes stored 
under the nitrogen umbrella store.
14,15 
 
Fig 8: Method of preparation of liposomes by hand shaking and non hand shaking
14 
PROCESS IN MORE DETAIL – 
Step1 
Lipid mixture of different phospholipid and charge 
components in chloroform :methanol solvent mixture 
(2:1v/v) is prepared first and then introduced into a round 
bottom flask with a ground glass neck,This flask is then 
attached to a rotary evaporator and rotated at 60 rpm.The 
orgnic solvent are evaproted at about 30 degree Celsius 
or above the transition temperature of the lipids usedThe 
evaprotor is isolated from the vaccume source by closing 
the tep.The nitrogen is introduced into the evaporator and 
the pressure  at the cylinder head is gradually raised till 
there is no difference between inside and out side the 
flask.The flask is then removed from the evaproter and 
fixed on to the manifold of lyophilizer to remove residual 
solvents 
Step2-hydration of lipid layer  
After releasing the vacume and removal from the 
lyophilizer ,the flask is flushed with nitrogen,5 ml of 
saline phosphate buffer (containing solute to be 
entrapped )is added.The flask is attached to the 
evaporator again (flushed with N2)and rotated at room 
temperature and pressure at the same speed or below 60 
rpm.The lask is left rotating for 30 minutes or unti all 
lipid has been removed from the wall of the flask and has 
given homogenous milky –whjite suspension free of 
visible particles.The suspension is allowed to stand for a 
further 2 hours at room temperature or at a temperature 
above the transition temparature of the lipid in order to 
complete the sweeling process to give MLVs.14 
 
Fig 9: Method of preparation of liposomes by 
hydration of lipid 
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SHAKING VESICLES  
Method described by reeves and dowben in 1996 by 
which large unicellular vesicles (LUVv) can be formed 
with higher entrapment volume.The procedure differs 
from hand shaken method in that it uses a stream of 
nitrogen to provide agitation rather than the rotationary 
movements.Solution of lipid in chloroform :methanol 
mixture is spred over the flat bottom conical flask.The 
solution is evaproted at room temparature by flow of 
nitrogen through the flask without disturbing the 
solutionAfter drying water saturated nitrogen is passed 
through the flask untill the opacity of the dried film 
disappears (15-20 mins).After hydration ,lipid is swelled  
by addition of bulk fluid .the flask is inclined to one side 
,10-20ml of 0.2 sucrose in distilled water (degassed)is 
introduced down the slide of the flask ,and the flask is 
slowly returned to upright orientation.The fluid is 
allowed to run gently over the lipid layer on the bottom 
of the flaskThe flask is fluhed with nitrogen ,sealed and 
allowed to stand for 2hours at 37 degrees celsius .take 
care not to disturb the flask in any way.Aftre swelling 
,the vesicles are harvested by swirling the contents ,to 
yield a milky –suspention.
14,15,16 
BUCHI ROTATORY EVAPORATOR NON 
SHAKING METHOD & PRO – LIPOSOMES:  
Pro liposomes method devised to increase the surface of 
dry lipid while keeping the low aqueous volume In this 
method , the lipid are dried down to finely divided 
particulate support ,such as powered  sodium chloride,or 
sorbitol or other polysacchride-to give pro-
liposomes.The lipid are swelled upon adding water to 
dried lipid coated powered (pro-liposomes),where the 
support rapidly dissolves to give a suspention of MLVs 
in aqueous solution.The size of the carrier influence the 
size and hetrogeneity of the liposomes.This method 
overcomes the problem encountered when storing 
liposomes themselves in either liquid ,dry or frozen form 
,and ois ideally suited for prparation where the material 
to be entrapped incoropted into lipid membrane,In case 
where 100% entrapment of aqueous component is not 
essential ,this method is also of valve.For preparing pro –
liposomes a special equipment i.e.buchi rotary evaproter 
„ R‟with water cooled condensor coil and a stainless steel 
covered thrmocouple connected to a digital thermometer 
is required.The end of glass solvent inlet tube is modified 
to a fine point ,so that the solvent is introdused into the 
flask as a fine spray.
14,15,16 
 
 
Fig 10: Method of preparation of liposomes by buchi 
rotatory evaporator 
 
SONICTION: 
This is the method in which Multi lamellar vesicles are 
transformed to the small uni lamellar vesicles. The ultra 
sonic irradiation is provided to the MLVs to get the 
SUVs. There are two methods are used.  a) Probe 
sonication method., b) Bath sonication method.The probe 
is employed for dispersion, which requires high energy 
in small volume (e.g. high conc. of lipids or a viscous 
aqueous phase) while is more suitable for large volumes 
of diluted liquid Probe tip sonicator provides high energy 
input to the liquid dispersion but suffer from over-
heating  of liposomal   dispersion causing lipid 
degradation. sonication tip also release titanium into the 
liposome dispersion which will be removed from the it 
by centrifugation prior to use. Due to above reason most 
widely the bath sonicators are used Sonication of MLVs 
is accomplished by placing dispersion into the the bath 
sonicator or placing tip fo probe sonicator  into the test 
tube of  dispersion.(5-10 min.)After sonication applied 
the resultant dispersion is centrifuged and according to 
diagram the SUVs will stay on the top and the small 
MLVs and aggregated lipids will get settled down. The 
top layer constitutes pure dispersion of SUVs with 
varying diameter as size is influenced by composition 
and concentration, temperature, sonication, volume and 
sonication tuning.15, 16 
 
Fig 11:  Method of preparation of liposomes by 
sonicaton 
FRECH PRESSURE CELL: 
This method is having the mechanism of high 
pressure.This method will give the either uni- or oligo- 
lamellar liposomes of intermediate size(30-80nm), these 
liposomes are more stable compared to the sonicated 
liposomes.This method is having some drawbacks are 
that  initial high cost for the press and the pressure cell 
liposomes prepared by this method having less structural 
defects unlike sonicated liposome .16,17 
MICRO EMULSIFICATION LIPOSOMES:-  
„Micro fluidizer‟ is used to prepare small MLVs from 
concentrated  Lipid dispersion.Micro fluidizer pumps the 
fluid at very at very high pressure (10,000 psi), through a 
5 micrometer orifice.Then, it is forced along defined 
micro channels which direct two streams of fluid to 
collide together at the right angles at a very high 
velocity, there by affecting  an efficient transfer of 
energy.The lipids can be introduced into the fluidizer, 
either as large MLVs or as the slurry of un hydrated lipid 
in organic medium. The fluid collected can be recycled 
through the the pump and interaction chamber until 
vesicles of spherical dimensions are obtained.  diameter 
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After a single pass, the size of vesicles is reduced to a 
size 0.1 and 0.2um . 
MEMBRANE EXTRUSION TECHNIQUE  
The technique can be used to process LUVs as well as 
MLVs.The size of liposomes is reduced by gently 
passing them through membrane filter of defined pore 
size achieved at much lower pressure(<100psi). In this 
process, the vesicles contents are exchanged with the 
dispersion medium during breaking and resealing of 
phospholipids bilayers as they pass through the 
polycarbonate membrane. The liposomes produced by 
this technique have been termed LUVETs. This 
techniques is most widely used method for SUV and 
LUV production for in vitro and in vivo studies . 
 
Fig 12: Method of preparation of liposomes by 
sonicaton 
DRIED RECONSTITUTED VESICLES (DRVS):-  
This method starts with freeze drying of a dispersion of 
empty SUVs. After freeze drying the freeze dried 
membrane is obtained.Then these freeze dried SUVs are 
rehydrated with the use aqueous fluid containing the 
material to be entrapped. This leads to formation of the 
solutes in uni- or oligo- lamellar vesicles. 
FREEZE THAW SONICATION: 
This method is based upon freezing of a unilamellar 
dispersion(SUV). Then thawing by standing at room 
temperature for 15min.Finally subjecting to a brief 
Sonication cycle which considerably reduces the 
permeability of the liposomes membrane. In order to 
prepare GIANT VESICLES of diameter between 10 and 
50um, the freeze thaw technique has been modified to 
incorporate a dialysis step against hypo- osmolar buffer 
in the place of sonication. The method is simple, rapid 
and mild for entrapped solutes, and results in a high 
proportion of large unilamellar vesicles formation which 
are useful for study of membrane transport 
phenomenon.This method is based upon freezing of a 
unilamellar dispersion(SUV). Then thawing by standing 
at room temperature for 15min. Finally subjecting to a 
brief Sonication cycle which considerably reduces the 
permeability of the liposomes membrane. In order to 
prepare GIANT VESICLES of diameter between 10 and 
50um, the freeze thaw technique has been modified to 
incorporate a dialysis step against hypo- osmolar buffer 
in the place of sonication. The method is simple, rapid 
and mild for entrapped solutes, and results in a high 
proportion of large unilamellar vesicles formation which 
are useful for study of membrane transport 
phenomenon.15,16,17
 
 
Fig 13: Method of preparation of liposomes by freeze thaw sonication 
PH INDUCED VESICULATION 
this method prepaer ULVs from MLVs without 
sonication or high pressure application ,they are 
reassembled by simply charging the ph .it is an 
electrostatic phenomenon ,the transfering chage in PH 
bring about an increase in the surface charge density of 
lipid bilayer ,provided this exceeeds a certain threshold 
valve of around 1-2uc/cm2,spontanous vesiculation will 
occur .the period of exposure of the phospholipid to high 
ph is less than 2min s and not long enough to cause 
detectable degratation of phospholipd.In this method ,dry 
film of lipid is obtained is the round bottom flask usin 
the rotatory evaporator and last traces of  the solvent are 
removed using freeze dryer.Then,the film is hydrated 
with minimum quantity of water by hand shaking at 
room temperature .At this stage material to be entrapped 
inside the vesicles may be added in the water before 
adddition to the lipid.The dispersion is completed by 
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subjecting the suspention to six freeze thawing cycle 
between 15 degree cesilsius and 5 degrees celsius.the PH 
of the despersion will be 2.5-3Sodium hydroxide 
solution (1m)is added rapidly with mmixing into the 
suspension then then the PH is redused by addition of 
0.1m hcl until a valve of PH 7.5 is achieved.17,18 
CALCIUM INDUSED FUSION – 
It uses concept of aggregation and fusion of acid 
phospholipid vesicles in the presence of calcium .In this 
method ,lipid is dried down and suspended in sonication 
buffer (Nacl 0.385g,histidin 31.0 mg ,this –base 24.2 mg 
,water 100ml ,PH 7.4)The large liposomes and lipid 
particles are removed by centrifugation at 
100,000g.Equimolar proportion of calcium solution 
precipite is formed It is incubeted for 60 mins at 37 
degree celsius and the precipitate is separated by 
spinning the container at 3000g for 2o min at room 
temperature .the supleemantant is dscarded.The pellet is 
resuspended is buffered saline containing the material to 
be entraped and incubated at 37 degrees celsius for 10 
min The EDTA (170mm) is added in buffer with mixing 
The cloudy precipite will clear rapidly ,then incubate for 
15 min at 37 degree celsius and further 15 min mix at 
room temparature.Finally,the ca/EDTA complex is 
removed by dialysing again a litre of buffer.18,19 
SOLVENT DISPERSION TECHNIQUES 
Ether and Ethanol Injection:- 
The method involves the extrusion of MLV at 20,000 psi 
at 4°C through a small orifice. The method has several 
advantages over sonication method. The method is 
simple rapid, reproducible and involves gentle handling 
of unstable materials (Hamilton and Guo, 1984).17, 
18Ethanol Injection Method A lipid solution of ethanol is 
rapidly injected to a vast excess of buffer. The MLVsare 
immediately formed. The drawbacks of the method are 
that the population is heterogeneous (30-110 nm), 
liposomes are very dilute, it is difficult to remove all 
ethanol because it forms azeotrope with water and the 
possibility of various biologically active macromolecules 
to inactivation in the presence of even low amounts of 
ethanol (Batzri and Korn, 1973).16 
 
Fig 14: Method of preparation of liposome’s by 
solvent dispersion techniques 
 
 Double Emulsion Vesicles:- 
In this method, the outer half of the liposome membrane 
is created at a second interphase between two phases by 
emulsification of an organic solution in water.If the 
organic solution, which already contains water droplet, is 
introduced into excess aqueous medium followed by 
mechanical dispersion, multi compartment vesicles are 
obtained. The ordered dispersion so obtained is described 
as W/O/W system. If the organic solution, which already 
contains water droplet, is introduced into excess aqueous 
medium followed by mechanical dispersion, multi 
compartment vesicles are obtained. The ordered 
dispersion so obtained is described as W/O/W system. At 
this step monolayers of phospholipids surrounding each 
water compartment are closely opposed by each other. 
The next step is to bring about the collapse of a certain 
proportion of the water droplets by vigorous shaking by 
using mechanical vortex mixer.Then the lipid monolayer 
which enclosed the collapsed vesicle is contributed to 
adjacent intact vesicle to form the outer leaflet of bilayer 
of large unilamellar liposomes.The vesicles formed are 
unilamellar and are having diameter of 0.5 micrometer. 
The encapsulation is found to be 50%. 16,17,18,19 
REVERSE PHASE EVAPORATION VESICLES: 
Sonicated methods (stable plurilamellar vesicles –SPVs) 
in this method ,w/o dispersion is prepared as described 
earlier with excess lipid ,but drying process is 
accompanined by continued bath sonication with a 
stream of nitrogen.The redistribution and equilibration of 
aqueous solvent and solute occur this time in between the 
various bilayer in each plurilamellar vesicles The internal 
structure of SPVs is different from that of MLV-REV,in 
that they lack a large aqueous medium being located in 
compartment in between adjucent lamellae.the percent  
entrapment is normally 30%.
18 
DETERGENT REMOVAL METHODS 
Detergent/Phospholipids mixtures can form large 
unilamellar vesicles upon removal of non ionic detergent 
using appropriate adsorbents for the detergent. in this 
method ,the phospholipid are brought into intimate 
contact with the aqueous phase via the intermediary of 
detergent ,which associated with phospholipid molucule 
from water,In structural formed as a result of this 
associated are known as micelles ,and can be composed 
of several hundred component molecules.Their shape 
and size depend on chemical nature of the detergent ,the 
concentration  and other lipid involved.The concentrated 
of detergent in water at which micelles from is known as 
critical micelle concentration(CMC).
18,19 
REMOTE OR ACTIVE LOADIND  
The membrane from lipid bilayer is in general  
impermeable to ions and larger hydrophilic molecules 
Ion  transport can be regulated by the ionophores while 
permeation of neutral 
and weakly hydrophobic moleculescan be controlled by c
oncentration gradients.Some weak acids or bases howeve
r, can be transported through  the membrane due to 
 various  trans membrane 
gradients, such as electrical, ionic (pH) or specific salt(ch
emical potential) gradiens Several 
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 methods exist for improved loading of the drugs,includi
ng remote (active) loading methods which load drug 
molecules into preformed liposomes using pH gradients 
and  potential  difference  
across liposomal membranesActive loading techniques 
are having following advantages over passive loading 
techniques.A high encapsulation efficiency and capacity. 
A reduced leakage of encapsulated compounds „Bed 
Side‟ loading of drugs thus loss of retention of drugs by 
diffusion or chemical degradation during storage. 
Reduction in hazards.19,20,21 
 
CHARACTERIZATION   
 Characterization parameters Analytical method/Instrument 
Vesicle shape and surface morphology 
Transmission electron microscopy,  
Freeze-fracture electron microscopy 
Mean vesicle size and size distribution  
   (submicron and micron range) 
Dynamic light scattering, zetasizer,  
Photon correlation spectroscopy, laser light scattering, gel permeation 
and gel exclusion 
Surface charge Free-flow electrophoresis 
Electrical surface potential and surface Ph Zetapotential measurements & pH sensitive probes 
 Lamellarity 
Small angle X-ray scattering, 31P-NMR,  Freeze-fracture electron 
microscopy 
Phase behavior Freeze-fracture electron microscopy, Differential scanning colorimetery 
Percent of free drug/ percent capture 
Minicolumn centrifugation, ion-exchange chromatography,  
radiolabelling 
Table 1: Physical characterization of liposomes 
CHEMICAL CHARACTERIZATION 
Characterization parameters Analytical method/Instrument 
Phospholipid concentration Barlett assay, stewart assay, HPLC 
Cholesterol concentration Cholesterol oxidase assay and HPLC 
Phopholipid peroxidation UV absorbance, Iodometric  and GLC 
Table 2: Chemical characterization of liposomes 
BIOLOGICAL CHARACTERIZATION 
Characterization parameters Analytical method/Instrument 
Sterility Aerobic or anaerobic cultures 
Pyrogenicity Limulus Amebocyte Lysate (LAL) test 
Animal toxicity Monitoring survival rates, histology and pathology 
Table 3: Biological characterization of liposomes 
 
PHYSICAL CHARACTERIZATION 
SIZE AND ITS DISTRIBUTION 
Most precise method to determine size of the liposome is
 by electron  microscopy,  since  it  allows   to view 
each individual liposome  and to obtain 
 exact information  about  the profile  of liposome 
 population  over the  whole range  of sizes. 
Unfortunately  it is  very  time  consuming  and requires  
equipments  thatmay  not always be immediately  
available to  hand .In  contrast,  laser  light  scattering 
 (quasi‐elastic laser light scattering) method is very  
simple and  rapid to perform but having disadvantage   
 of measuring an average property of the bulk of the 
liposomes.21,22 
MICROSCOPIC METHODS 
Light microscopy 
 has been utilized to examine the gross size/distribution o
f  large  vesicles  produced  from single chain 
amphiphilesIf the bilayers are  having  fluorescent  
hydrophilic  probes, the liposomes can be examined 
 under a fluorescent microscope. The resolution 
of the light microscope limits this technique for 
obtaining the complete size distribution 
of the preparation. but using  negative stain 
 electron microscopy,  one can obtain an estimate  
of the lower end of the size distribution.For the large vesi
cles  (5um),  negative  stain electron  microscopy is 
 not suitable  for determination  of the  size distribution  
be cause  vesicle  distortion during  preparation of 
 the specimen makes  it difficult  to obtain an  
estimate of the diameter of the original  particle. 
A technical  difficulty  in obtaining  good  negativestains  
of  liposomes  is the  spreading  of thevesicles 
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on the carbon‐coated  
grid.Treating the grid with 0.1mg/mL solution of  
bacitracinor  coating  the  support  films with silica 
 by the evaporation 
 of silicon monoxide,usually permits a satisfactory sprea
ding of liposomes  for  negative staining. Glow  
discharging  of the  grids  immediately  priorto  use  is of 
 considerable  help to  the spreading of liposomes 
 on the grid surface. 
Freeze etch and freeze fracture electron microscopy 
techniques have been  used to study  vesicle size and 
structure.21,22,23 
 
Fig 15: Structure of liposomes by 
microscopic methods 
GEL PERMEATION  
Exclusion chromatography on large pure gels was 
introduced to  separate SUVs  from  radial  
MLVs.However, large vesicles of 1‐3 um diameter usuall
y failto enter the gel and are retained on the  top of the 
column.A thin layer chromatography system using agaro
se beads  has  been  introduced  as a convenient, fast 
technique  for obtaining  a rough  estimation  of the  size 
distribution  of a liposomes  preparation. However, 
 it was not  reported if  this procedure  was sensitive 
 to a physical  blockage of the pores of the agarose gel 
 as  is  the more  conventional  column chromatography.  
B) SURFACE CHARGE  
 A method using free flow electrophoresis is used to dete
rmine the surface charge of MLVs, A  
technique has been developed that separates extruded ves
icles on the basis of their  surface  charge   by 
electrophoresis on a cellulose acetate plate   in  a  sodium 
 borate  buffer  pH 8.8. The lipid samples 
(5 nmoles) are applied to the plate and electrophoresisis 
carried out at 4 
degrees Celsiuson a flat bed apparatus for 30 mins at 18
V/cm.The plate is dried and the phospholipids are visuali
zed by the molybdenum blue reagent. Liposomes  upto 
0.2 um in  diameter  can migrate 
 on this support and with this technique  
as little as 2 mole %  of  charged  lipids can be detected  
in  a liposome  bilayer. This sensitive  assay  should 
 prove  valuable for examining the charge 
heterogeneity in  liposome preparation  for following  
fusion between  two populations  of vesicles 
 with different charge and for determining. 
C) PERCENT CAPTURE (ENTRAPMENT)    
It is essential to measure the quantity of material entrapp
ed in side  liposomes  before the study  
of behavior of this entrapped material  in physical 
 and biological  systems, since the effects observed  
experimentally  will usually be dose  related. 
After removal of un 
incorporated material by the separation 
techniques, one may assume that the quantity of material 
remaining 
is 100% entrapped, but the preparation may change 
upon storage. For  long term stability test  and for  
developing  new liposome formulation  or method of 
 preparation, a  technique is needed for separating  
free from entrapped material.22,23,24 
MINI COLUMN CENTRIFUGATION METHOD  
In this method, the hydrated gel (sephadexG‐50) is filled 
in a barrel of 1mL syringe without 
plunger which is plugged with a whatman 
GF/B filter pad. This barrel is rested in a centrifuge 
tube. This tube is spun at 2000 rpm for 3  mins to remove 
 excess saline  solution fromthe gel. After  centrifugation  
 the gel column  should be dried and have come away  
from the side  of the barrel Then,  eluted  saline is  
removed  from the  collection  tube.Liposome 
 suspension  (0.2mL  undiluted)   is applied  drop wise 
to the  top of  the gel bed,  and  the  column 
 is spun at 2000 rpm for  3 min.  to expel 
 the void volume  containing the liposomes into  
the centrifuge  tube.The elute  is then removed  and set a 
side  for assay. 23, 24, 25 
D)ENTRAPPED VOLUME     
The entrapped volume of a population of liposomes (inu
L/mg phospholipid) can often be  reduced from 
measurements  of the total quantity  of solute entrapped 
in side  liposomes  assuring 
 that the concentration of solute 
in the aqueous medium inside liposomes is the same as 
that in the  solution  used to  start with,  and assuming  
that no solute  has leaked  out of the liposomes 
 after separation from unentrapped material.However,  in 
 many  cases such  assumption   is invalid.  
For e.g.,in two  phase methods of  preparation, water  
can be lost from  the internal  compartment  
during the drying  down 
step to remove organic solvent.25,26,27 
E) LAMELLARITY  
The average number of bilayers present  in a  liposome 
 can be found  by  freeze  electron    microscopy and 
by 31P‐NMR.In the latter technique, the signals are 
 recorded  before  and 
after the addition of broadening agent such as manganese
ions which inteact with the outer leaflet of the outer most 
bilayers.  Thus, a  50% reduction  in NMR  signal means 
 that the liposome preparation is unilamellar and  a 25% 
reduction  in  the  intensity  
of the original NMR signal means that  
there are 2 bilayers in the  liposom Nowadays,  freeze  
fracturing  electron  
microscopy hasbecome a very popular methd to study str
uctural details of  aqueous  lipid  dispersions. Phase  
Behavior  of  Liposomes An  important  feature 
 of lipid membrane  is  the  existence  of a temperature 
 dependant,  reversible  phase transition,  where the 
hydrocarbon chains of the phospholipid undergo 
 a transformation from an ordered  (gel) state to a  
more disordered fluid  (liquid crystalline)  state.These 
 change  have been  documented  
by freeze fracture electronmicroscopy, but most easily de
monstrated  by  differential   scanning calorimetery. 
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The physical state of the bilayers pro foundly affects the 
permeability, leakage rates and overall stability 
of the liposomes. The phase transition 
temperature (Tc) is a function of phospholipid 
content of the bilayers.The Tc can give good 
clues regarding liposomal stability, 
permeability and whether drug is entrapped in the bilayer
s or the aqueous compartment. 
DRUG RELEASE  
The mechanism of drug release from the liposomes can b
eassessed by the use of a well calibrated in vitro diffusio
n 
cell.The liposome based formulations can be assisted by 
employing  in  vitro  assays 
 to predict pharmacokinetics and bioavailability  of the 
 drug before  employing  costly and time‐consuming  in 
 vivo  studies. The  dilution‐induced  drug release  
in buffer and  plasma was  employed  as predictor 
 for pharmacokinetic performance  of liposomal 
 formulations and another assay which  determined  
intracellular  drug release  induced by liposomes  
degradation in the presence of mouse‐liver lysosome 
lysate was  used  to  assess  the bioavailability of 
the drug.28,29,30 
 CHEMICAL CHARACTERIZATION 
A) QUANTITATIVE DETERMINATION   OF 
PHOSPHOLIPIDS 
 It is difficult to measure directly the phospholipid 
concentration, since dried lipids can often contain 
considerable quantities of residual solvent. 
Consequently  the  method  most widely used   for  
determination  of  phospholipidis  an  indirect  one in  
which  the  phosphate  content  of  the  sample  is first  
measured , The  phospholipids are measured either using 
Bartlett  assay  or  Stewart   Assay .29,30,31 
Bartlett Assay  
In the Bartlett assay the phospholipid phosphorous in the 
sample is first hydrolyzed  to inorganic phosphate. 
This is  converted  to phospho‐molybdic acid  by the 
 addition ammonium  molybdate and   phospho‐molybdic  
acid is quantitatively to  a blue  colored  compound  by 
 amino‐ naphthyl‐  sulfonic   acid.  The intensity  
of the blue color  is measured  spectrophotometrically    
and  is  compared  with the  curve of  standards  to  give  
phosphorous  and hence phosphorlipid content Bartlett 
 assay  is very  sensitive  but is not  reasonably 
 reproducible. The problem 
is that the test is easily upset by trace contamination with 
inorganic phosphate.  Therefore, 
 precaution is to be taken using  a set  of borosilicate  
glass tubes  which are  washed well 
 and not usedfor any other purpose.Use of double‐distille
d water for making up solutions.The sensitivity of the Ba
rtlett assay to inorganic phosphate creates problem  
with measurement  of phospholipid  liposomes 
 suspended  in physiological  buffers,  which  usually 
 contain phosphate ions. This can beovercome by employ
ing a more specific method which Is unaffected by 
inorganic phosphate.32, 33 
 
STEWART ASSAY 
In Stewart assay, the phospholipid forms a complex with 
ammonium  ferrothiocyanate in organic 
 solution.The advantage of this method is that the presen
ce ofinorganic phosphate does not interfere with the assa
y.This method is not applicable to samples  where 
 mixture of  unknown  
phospholipids may be present.In this method, the standar
d curve is first prepared byadding ammonium ferrothiocy
anate(0.1M) solution with different  known  
concentrations  of phospholipids  in chloro form. 
Similarly, the samples are treated and optical density of 
these solutions is measured at 485nm the 
absorbance of samples compared with the standard 
curve of  phospholipids   to get the concentration. 
B) PHOSPHOLIPIDS OXIDATION  
 Oxidation of the fatty acids of phospholipids in the abse
nceof specific oxidants occurs via a free radical chain 
mechanism. The initiation step is abstraction of 
a hydrogen atom from the 
lipid chain that can occur most commonly as a result ofe
xposure to electro‐magnetic radiation or trace amount of 
contamination with the transition metal ions. 
Polychain‐saturated 
lipids are particularly prone toxidative degradation.A nu
mber of techniques are available for determining the 
oxidation  of phospholipids  at different stages 
 i.e., UVabsorbance  
method, TBA method (for endoperoxides), iodometric 
method  (for  hydroperoxides)  and GLC method. 33, 34, 35 
C) CHOLESTEROL ANALYSIS  
Cholesterol is qualitatively analyzed using 
capillary column of flexible fused silica where as it is  
quantitatively estimated (in therange of 0‐8ug) by measur
ing the absorbance of purple complex   
 produced with iron upon 
reaction with a combined reagent containing ferric  per 
chlorate  ,  ethyl  acetate and sulfuric acid at 610nm. 36, 37
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APPLICATION
 
Application  Utilized  
Liposomes in 
bioengineering 
Modern genetic engineering and gene recombinant technology is based on the deliveryof 
genetic material, i.e. fragments of DNA, into various cells and microorganismsin order to alter 
their genetic code and force them to produce particular proteins or 
Polypeptides 
Medical applications 
of stealth liposomes 
Sterically stabilised vesicles can act either as long circulating microreservoirs or       tumour  
(or site of inflammation and infection) targetting vehicles. The former application srequires 
larger liposomes   (_ 0.2 _m) while the latter one is due to the ability of small vesicles to leave 
the blood circulation38 
Liposomes in 
anticancer therap 
These cells are in tumours, but also in gastrointestinal mucosa, hair, and blood cells and 
therefore this class of drugs are very toxic. The most used andstudied is Adriamycin 
(commercial name for Doxorubicin HCl). 
Macrophage 
activation and 
vaccination 
The automatic targetting of liposomes to macrophages can be exploited in several 
other ways, including the macrophage activation and in vaccination 
Liposomes in 
parasitic diseases and 
infections 
Since conventional liposomes are digested by phagocytic cells in the body after intravenous 
administration, they are ideal vehicles for the targetting of drug molecules 
into these macrophages 
Applications of 
liposomes in basic 
sciences 
Lipid membranes are two dimensional surfaces floating in three dimensional space.In the   
simplest models, they can be characterised only by their flexibility which is related to their 
bending elasticity.39,40 
Application of 
liposomes in agro-
food industry 
 
The ability of liposomes to solubilize compounds with demanding solubility properties, 
sequester compounds from potentially harmful milieu, and release incorporated molecules in a 
sustained and predictable fashion can be used also in the food processing industry For instance, 
lecithin and some other polar lipids are routinely extracted from nutrients, such as egg yolks or 
soya beans.40,41 
Table 4: Application of Liposomes 
 
Liposome Utility Current Applications Disease States Treated 
Solubilization Amphotericin B, minoxidil Fungal infections 
Site-Avoidance Amphotericin B – reduced nephrotoxicity, Fungal infections, 
cancer doxorubicin – decreased cardiotoxicity 
Fungal infections 
Sustained-Release Systemic antineoplastic drugs, hormones, Cancer, 
biotherapeutics corticosteroids, drug depot in the lungs 
Cancer, biotherapeutics 
Drug protection Cytosine arabinoside, interleukins Cancer, etc. 
RES Targeting Immunomodulators, vaccines, antimalarials, Cancer, MAI, 
tropical parasites macophage-located diseases 
Cancer, MAI, tropical 
Specific Targeting Cells bearing specific antigens Wide therapeutic 
Accumulation Prostaglandins Cardiovascular diseases42,43,44 
Table 5: Liposomes in the pharmaceutical industry 
 
Product Manufacturer Liposomes and key ingredients 
Efect du Soleil L‟Or´eal Tanning agents in liposomes Niosomes Lancome 
Niosomes Lancome (L‟Or´eal) Glyceropolyether with moisturizers 
Nactosomes Lancome (L‟Or´eal Vitamins 
Formule Liposome Gel Payot (Ferdinand Muehlens) Thymoxin, hyaluronic acid 
Future Perfect Skin Gel Estee Lauder TMF, vitamins E, A palmitate, cerebroside ceramide, 
phospholipid 
Symphatic 2000 Biopharm GmbH Thymus extract, vitamin A palmitate 
Natipide II Nattermann PL Liposomal gel for do-it-yourself 
Flawless finish Elizabeth Arden Liquid make-up 
Inovita Pharm/Apotheke Thymus extract, hyaluronic 
Eye Perfector Avon Soothing cream to reduce eye45,46,47 
Table 6: Some liposomal cosmetic formulations currently on the market
48,49,50 
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Marketed product Drug used Target diseases Company 
DoxilTM or 
CaelyxTM  
Doxorubicin  Kaposi‟s sarcoma  SEQUUS, USA  
DaunoXomeTM  DaunSolid 
tumoursorubicin  
Kaposi‟s sarcoma, breast & lung 
cancer  
NeXstar, USA  
AmphotecTM  Amphotericin-B   fungal infections, Leishmaniasis  SEQUUS, USA  
Fungizone®  Amphotericin-B   fungal infections, Leishmaniasis  Bristol-squibb, Netherland  
VENTUSTM  Prostaglandin-E1  Systemic inflammatory diseases  The liposome company, USA  
ALECTM  Dry protein free 
powder of DPPC-PG  
Expanding lung diseases in babies  Britannia Pharm, UK  
Topex-Br  Terbutaline sulphate  Asthma  Ozone, USA  
Depocyt  Cytarabine  Cancer therapy  Skye Pharm, USA  
Novasome®  Smallpox vaccine  Smallpox  Novavax, USA  
Avian retrovirus 
vaccine  
Killed avian retrovirus  Chicken pox  Vineland lab, USA  
Doxil®  Doxorubicin Hcl  Refractory ovarian cancer  ALZA, USA  
EvacetTM  Doxorubicin  Metastatic breast cancer  The liposome company, USA  
Table 7: list of marketed products
 
 
WORLD MARKET OF LIPOSOMES: 
The liposomes are among the drug carrier being 
extensively used today. This category of drug delivery 
system has occupied a major area in the world market. 
There is no place in the world left where liposomes have 
not been marketed. Among the major areas Western 
Europe with 13% of the total market dominates followed 
by North America and South Asia with contribution of 
12% and 11% respectively.  
 
Fig 16: Representing the world market share of 
Liposome Business 
53, 54 
The area like Oceania is also influenced by the liposomal 
preparations and contributed approximately 8% to the 
world market.51,52,53 
CONCLUSION: 
This review presented the hardest aspect of choice for 
any material. Since they have been discovered in the 60‟s 
by Bingham, liposomes have drawn attention of 
researchers. Nowadays, they always remain a topical 
issue; new preparation methods have been developed as 
well as new characterization techniques. In the 
pharmaceutical field, liposome‟s have long been of great 
interest by offering a promising way for both systemic 
and locally acting drugs used for therapeutic applications 
in humans and animals. As a result of the great potential 
of liposomes in the area of drug delivery, several 
companies have been actively engaged in expansion and 
evaluation of liposome products. Most of them concern 
anticancer and antifungal drugs that, administered in 
their free form, are toxic or exhibit serious side-effects 
and their encapsulation into liposomal vesicles 
significantly diminishes these unwanted properties. With 
these requirements met, we are surely likely to see more 
liposomal pharmaceuticals on the market in the 
foreseeable future. 
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